How do I know if Tirzepatide will work for me: 7 factors
According to this Medscape overview,
Investigators conducted a post hoc analysis of data collected from a total of 3188 people with type 2 diabetes who had been adherent to their assigned Tirzepatide regimen for 40–42 weeks in any one of four pivotal trials of the agent: SURPASS-1, SURPASS-2, SURPASS-3, and SURPASS-4.
- Higher Tirzepatide dose
- Being female
- Being of White or Asian race
- Being of younger age
- Undergoing treatment with metformin
- Having better glycemic control (based on lower A1c and lower fasting serum glucose)
- Having lower non-high-density lipoprotein (non-HDL) cholesterol level.
Do these factors describe you?